Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Domingo, ChristianRabe, Klaus F.Price, DavidBrusselle, GuyWechsler, Michael E.Xia, ChangmingPandit-Abid, NamiGall, RebeccaRowe, Paul J.Deniz, YamoJacob-Nara, Juby A.Radwan, Amr2023-10-102023-10-102023-09Domingo, C, Rabe, K F, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Rowe, P J, Deniz, Y, Jacob-Nara, J A & Radwan, A 2023, 'Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose', ERJ Open Research, vol. 9, no. 6. https://doi.org/10.1183/23120541.00056-20232312-0541Bibtex: Domingo00056-2023https://hdl.handle.net/2164/21891FUNDING Regeneron Pharmaceuticals NCT0213402; NCT02528214 Sanofi NCT0213402; NCT02528214371407278engR MedicineRLong-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid doseJournal article10.1183/23120541.00056-202396